CoreRx® a CDMO with a focus on early phase drug product development, offering state of the art facilities to support your supply chain needs throughout the entire clinical trial process. Our integrated offerings provide comprehensive services for the development, manufacturing and testing of solid, liquid and semi-solid dosage forms.
The art of drug product development is the core of what we do. We differentiate ourselves by mixing highly experienced scientists with a wide range of technologies to deliver optimal solutions to meet our clients’ needs. From simple formulations to complex, delayed or targeted release dosage forms, CoreRx’s solutions maximize client investments, shorten development time and reduce overall costs.
At CoreRx, you bring us your formulation challenge and we will supply the right ingredients to ensure your product reaches its maximum potential.
The Instillo group, consolidates an independent group of companies which operates over 20 countries world wide. It has established a strong network and built up a competitive team offering their expert knowledge for a number of national and international companies in a trustworthy working environment.
Through its partnership with the Instillo group, leon nanodrugs is the exclusive license owner of the MicroJet Reactor technology for all pharmaceutical applications for all dosage forms.
The Goodman Pediatric Formulations Centre (GPFC), is a not-for-profit organization. The overall goal of the Centre is to improve access to child-friendly medicines. GPFCs mandate is to facilitate the development of commercially available age-appropriate formulations for children. Promoting practices to increase the safety of medicines administered to children is part of their mission.
Collaboration with leon-nanodrugs:
“The Goodman Pediatric Formulations Centre of the CHU Sainte-Justine started a collaboration with Leon-Nanodrugs that has solidified over time. Their team shares our vision of pediatrics and adheres to our mission to provide children with medications that meet their needs. Leon Nanodrugs has in-depth knowledge of nanotechnology, and with their innovative approach, we hope to achieve breakthroughs in pediatric formulations. “